Sutton Wealth Advisors’s NovoCure NVCR Stock Holding History

Sutton Wealth Advisors’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-17	Closed	-$1.41K	–	1689
2022 Q1	$1.41K	Buy	+17	New	+$1.25K	﹤0.01%	1256
2021 Q3	–	Sell	-5	Closed	-$1.11K	–	1328
2021 Q2	$1.11K	Buy	+5	New	+$973	﹤0.01%	1221

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sutton Wealth Advisors's NVCR Position: Q2 2022 in Review

Sutton Wealth Advisors sold out of NovoCure (NVCR) in Q2 2022, closing a stake of 17 shares — an estimated $1.41K sold.

Sutton Wealth Advisors first reported a position in NVCR in Q2 2021 and held it in 2 quarters. The position peaked at $1.41K in Q1 2022. 316 funds tracked by Wall St. Rank hold NVCR as of Q2 2022.

Sutton Wealth Advisors reported no remaining NovoCure position as of Q2 2022 after selling out during the quarter.
Sutton Wealth Advisors sold 17 NovoCure shares in Q2 2022, an estimated $1.41K.
Sutton Wealth Advisors first reported a position in NovoCure in Q2 2021 and held it in 2 quarters.
Sutton Wealth Advisors's NovoCure position peaked at $1.41K in Q1 2022.
316 funds tracked by Wall St. Rank held NovoCure as of Q2 2022.

Based on Sutton Wealth Advisors's 13F filing for Q2 2022, filed 7 Nov 2023.